Using artificial intelligence to prioritize pathology samples: report of a test drive
Ethics approval and consent to participate
Formal ethical approval was not required for this study, as it did not involve any patient data collection or impact on patient care.
Conflict of interest
CE consulted for Mindpeak, MSD, Biocartis, Diapath, Sakura, and Leica during the last 2 years. AP consulted for Indica Labs for the last 2 years. The use of the Paige Pan Cancer was warranted by Paige AI.
Comments (0)